Development
NeueHealth, Inc.
NEUE
$6.77
$0.000.00%
NYSE
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 74.25% | -114.48% | -15.35% |
| Total Depreciation and Amortization | -- | -- | -4.91% | 16.26% | 160.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -68.78% | -41.45% | 176.71% |
| Change in Net Operating Assets | -- | -- | -172.06% | 233.21% | -214.90% |
| Cash from Operations | -- | -- | -601.19% | 119.96% | -354.18% |
| Capital Expenditure | -- | -- | 68.26% | 8.65% | 33.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1,648.94% | -92.06% | 260.25% |
| Cash from Investing | -- | -- | 1,954.53% | -93.16% | 253.37% |
| Total Debt Issued | -- | -- | -- | -151.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00% | -99.84% | 54.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 20.80% | -1,551.45% | 92.71% |
| Cash from Financing | -- | -- | -101.06% | -43.95% | 20,684.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -78.59% | 83.59% | 328.13% |